Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells.

Abstract

The findings of the current study suggest that our combination strategy, which merges two detached gene (p53) and drug (curcumin) delivery systems into an integrated platform, may represent huge potential as a novel and efficient modality for glioblastoma treatment.